Are you Dr. Nattam?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 55 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2514 E DuPont Rd
Ste 100
Fort Wayne, IN 46825Phone+1 260-484-8830Fax+1 260-483-1911
Summary
- Dr. Sreenivasa Nattam, MD is an oncologist in Fort Wayne, Indiana. He is currently licensed to practice medicine in Indiana and Michigan. He is affiliated with Dupont Hospital, Lutheran Hospital of Indiana, and Parkview Noble Hospital.
Education & Training
- Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1981
- Advocate Health Care/Advocate Illinois Masonic Medical CenterResidency, Internal Medicine, 1976 - 1979
- Columbus HospitalInternship, Transitional Year, 1975 - 1976
- Sri Venkatesvara Medical College NTRClass of 1975
Certifications & Licensure
- IN State Medical License 1981 - 2025
- MI State Medical License Active through 1983
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2014
Clinical Trials
- Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia Start of enrollment: 1999 Apr 01
- Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Start of enrollment: 1984 Jun 01
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsFollow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema
Blood. 2024-04-18 - 22 citationsPhase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas.Ajay Major, Justin Kline, Theodore Karrison, Paul A. S. Fishkin, Amy S. Kimball
Haematologica. 2021-07-29 - 13 citationsAdverse event burden in older patients with CLL receiving bendamustine plus rituximab or ibrutinib regimens: Alliance A041202.Amy S. Ruppert, Allison M Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander
Leukemia. 2021-07-17